MS icon

Morgan Stanley

131.69 USD
-2.65
1.97%
At close Feb 21, 4:00 PM EST
After hours
131.80
+0.11
0.08%
1 day
-1.97%
5 days
-3.49%
1 month
-4.09%
3 months
-2.44%
6 months
30.79%
Year to date
5.54%
1 year
54.10%
5 years
151.22%
10 years
263.08%
 

About: Morgan Stanley is a global investment bank whose history, through its legacy firms, can be traced back to 1924. The company has institutional securities, wealth management, and investment management segments with approximately 45% of net revenue from its institutional securities business, 45% from wealth management, and 10% from investment management. About 30% of its total revenue is from outside the Americas. The company had over $5 trillion of client assets as well as around 80,000 employees at the end of 2023.

Employees: 80,000

0
Funds holding %
of 7,139 funds
0
Analysts bullish %
of 8 analysts

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

283% more first-time investments, than exits

New positions opened: 314 | Existing positions closed: 82

85% more funds holding in top 10

Funds holding in top 10: 20 [Q3] → 37 (+17) [Q4]

20% more capital invested

Capital invested by funds: $144B [Q3] → $172B (+$28.6B) [Q4]

8% more funds holding

Funds holding: 1,837 [Q3] → 1,983 (+146) [Q4]

0.81% less ownership

Funds ownership: 84.83% [Q3] → 84.03% (-0.81%) [Q4]

11% less repeat investments, than reductions

Existing positions increased: 670 | Existing positions reduced: 754

28% less call options, than puts

Call options by funds: $3.28B | Put options by funds: $4.58B

Research analyst outlook

8 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$124
6%
downside
Avg. target
$142
8%
upside
High target
$156
18%
upside

8 analyst ratings

positive
38%
neutral
63%
negative
0%
UBS
Brennan Hawken
74% 1-year accuracy
25 / 34 met price target
6%upside
$140
Neutral
Maintained
21 Jan 2025
Barclays
Jason Goldberg
75% 1-year accuracy
42 / 56 met price target
18%upside
$156
Overweight
Maintained
17 Jan 2025
B of A Securities
Michael Carrier
100% 1-year accuracy
6 / 6 met price target
16%upside
$153
Buy
Maintained
17 Jan 2025
Evercore ISI Group
Glenn Schorr
83% 1-year accuracy
30 / 36 met price target
14%upside
$150
Outperform
Maintained
17 Jan 2025
JP Morgan
Kian Abouhossein
100% 1-year accuracy
7 / 7 met price target
6%downside
$124
Neutral
Maintained
17 Jan 2025

Financial journalist opinion

Based on 35 articles about MS published over the past 30 days

Neutral
Zacks Investment Research
13 hours ago
Morgan Stanley (MS) Declines More Than Market: Some Information for Investors
In the most recent trading session, Morgan Stanley (MS) closed at $131.69, indicating a -1.97% shift from the previous trading day.
Morgan Stanley (MS) Declines More Than Market: Some Information for Investors
Positive
Zacks Investment Research
16 hours ago
MS Shares Gain 33.4% in 6 Months: Buy Before the Stock Soars Further?
Morgan Stanley stock is up 33.4% in the past six months. Is this the perfect time to buy, or has the opportunity already passed?
MS Shares Gain 33.4% in 6 Months: Buy Before the Stock Soars Further?
Negative
Proactive Investors
1 day ago
HSBC and four other banks agree settlement after rigging UK govt bond auctions
Fines of just £100 million have been dished out to bankers from HSBC Holdings PLC (LSE:HSBA), Citigroup Inc (NYSE:C), Morgan Stanley (NYSE:MS) and Royal Bank of Canada (TSX:RY) for rigging UK government bond sales.  The bankers unlawfully shared what would normally be competitively sensitive information about aspects of the pricing of gilts between 2009-2013, using Bloomberg's one-to-one chat messaging platform.
HSBC and four other banks agree settlement after rigging UK govt bond auctions
Neutral
CNBC Television
1 day ago
Final Trade: EEM, BABA, MS, NEM
The final trades of the day with CNBC's Brian Sullivan and the Fast Money traders.
Final Trade: EEM, BABA, MS, NEM
Negative
The Motley Fool
1 day ago
Why Bank Stocks JPMorgan Chase, Goldman Sachs, and Morgan Stanley Fell Today
Bank stocks struggled today as investors grew more concerned about the economy and the strength of consumers. Shares of JPMorgan Chase (JPM -4.46%), the largest bank in the U.S. by assets, fell 4.5%.
Why Bank Stocks JPMorgan Chase, Goldman Sachs, and Morgan Stanley Fell Today
Positive
Zacks Investment Research
1 day ago
Are You Looking for a High-Growth Dividend Stock?
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Morgan Stanley (MS) have what it takes?
Are You Looking for a High-Growth Dividend Stock?
Negative
Zacks Investment Research
2 days ago
Morgan Stanley (MS) Stock Falls Amid Market Uptick: What Investors Need to Know
In the closing of the recent trading day, Morgan Stanley (MS) stood at $140.69, denoting a -0.01% change from the preceding trading day.
Morgan Stanley (MS) Stock Falls Amid Market Uptick: What Investors Need to Know
Positive
Seeking Alpha
1 week ago
Our Top 10 Dividend High-Growth Stocks - February 2025
This monthly article focuses on selecting high-growth dividend stocks with rapidly growing dividends rather than high current yields. We use our proprietary models to rate quantitatively and qualitatively and select the top ten names from an initial list of nearly 400 dividend stocks. The final list of ten stocks is chosen based on sector diversity, high-growth quality scores, and positive momentum, suitable for investors in the accumulation phase.
Our Top 10 Dividend High-Growth Stocks - February 2025
Neutral
Business Wire
1 week ago
E*TRADE from Morgan Stanley Recognized as #1 Web Trading Platform by StockBrokers.com
NEW YORK--(BUSINESS WIRE)--E*TRADE from Morgan Stanley today announced multiple top honors from the StockBrokers.com 2025 Annual Awards. E*TRADE earned 5 out of 5 stars overall and was ranked the #1 Web Trading Platform for the 13th year in a row. E*TRADE also received “Best in Class” distinctions in 15 categories: Overall: Best in Class 15 years running Mobile Trading Apps: Best in Class 13 years running Platforms & Tools: Best in Class three years running Range of Investments: Best in Cla.
E*TRADE from Morgan Stanley Recognized as #1 Web Trading Platform by StockBrokers.com
Negative
Market Watch
1 week ago
Biogen's stock hit by soft guidance and a decline in sales of MS drugs
Sales of an Alzheimer's disease treatment were better than expected, but that and a quarterly beat wasn't enough to offset below-consensus EPS outlook.
Biogen's stock hit by soft guidance and a decline in sales of MS drugs
Charts implemented using Lightweight Charts™